Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Dementia01:30

Dementia

417
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
417
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

1.4K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.4K
Cognitive Development During Adulthood01:30

Cognitive Development During Adulthood

645
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
645
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists01:30

Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists

431
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
431

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Differential Effects of Pre-Stroke Antithrombotic Medication on Clinical Outcomes of Patients with Hyperhomocysteinemia and First-Ever Stroke Versus Recurrent Stroke.

Journal of clinical medicine·2025
Same author

Family's Caregiving Status and Post-Stroke Functional Recovery During Subacute Period from Discharge to Home: A Retrospective Study.

Journal of clinical medicine·2024
Same author

Recurrent Ischemic Stroke and Transient Ischemic Attack: Risk of Single and Multiple Recurrence.

Journal of clinical medicine·2024
Same author

Predicting short-term outcomes in atrial-fibrillation-related stroke using machine learning.

Frontiers in neurology·2023
Same author

Obesity paradox and stroke outcomes according to stroke subtype: a propensity score-matched analysis.

International journal of obesity (2005)·2023
Same author

Plasminogen Activator Inhibitor-1: Potential Inflammatory Marker in Late-life Depression.

Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology·2023

Related Experiment Video

Updated: Dec 15, 2025

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.8K

Mild cognitive impairment, dementia, and cognitive dysfunction screening using machine learning.

Daehyuk Yim1, Tae Young Yeo1, Moon Ho Park1

  • 1Department of Neurology, Korea University Ansan Hospital, Ansan, Republic of Korea.

The Journal of International Medical Research
|July 10, 2020
PubMed
Summary
This summary is machine-generated.

Machine learning algorithms show high accuracy in identifying mild cognitive impairment (MCI) and dementia using standard screening tests. This AI tool can support clinicians in diagnosing cognitive dysfunction.

Keywords:
Machine learningcognitive dysfunctiondementiadiagnostic toolmild cognitive impairmentscreening

More Related Videos

The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
06:23

The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease

Published on: October 13, 2016

33.5K
Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
04:33

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression

Published on: April 26, 2024

1.1K

Related Experiment Videos

Last Updated: Dec 15, 2025

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment
12:18

A Machine Learning Approach to Design an Efficient Selective Screening of Mild Cognitive Impairment

Published on: January 11, 2020

7.8K
The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease
06:23

The 4 Mountains Test: A Short Test of Spatial Memory with High Sensitivity for the Diagnosis of Pre-dementia Alzheimer's Disease

Published on: October 13, 2016

33.5K
Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression
04:33

Author Spotlight: Unveiling the Connection Between Sleep Disorders and Cognitive Symptoms in Depression

Published on: April 26, 2024

1.1K

Area of Science:

  • Artificial Intelligence in Medicine
  • Neuroscience
  • Cognitive Health

Background:

  • Cognitive dysfunction, including mild cognitive impairment (MCI) and dementia, poses a significant public health challenge.
  • Accurate and early screening for cognitive decline is crucial for timely intervention and management.
  • Current screening methods can be enhanced with advanced analytical tools.

Purpose of the Study:

  • To develop and evaluate a machine learning (ML) algorithm for identifying cognitive dysfunction.
  • To assess the algorithm's performance using neuropsychological screening test results.

Main Methods:

  • A retrospective study involving 955 participants (341 dementia, 333 MCI, 341 cognitively healthy).
  • Utilized data from the Mini-Mental State Examination, Montreal Cognitive Assessment, and Korean Dementia Screening Questionnaire.
  • Applied various machine learning algorithms and calculated performance metrics including accuracy, Cohen's kappa, and AUC.

Main Results:

  • Machine learning algorithms achieved high screening accuracies: 67.8%–93.5% for MCI, 96.8%–99.9% for dementia, and 75.8%–99.9% for overall cognitive dysfunction.
  • Kappa statistics ranged from 0.351 to 1.000, indicating good to excellent agreement.
  • The ML models demonstrated statistically superior Area Under the Curve (AUC) values compared to existing screening models.

Conclusions:

  • Machine learning algorithms show promise as effective tools for screening cognitive dysfunction.
  • These AI-driven approaches can serve as valuable supportive instruments for clinicians in identifying MCI and dementia.
  • Further integration of ML in cognitive screening may improve diagnostic efficiency and patient outcomes.